My program of research is focused on the epigenetics of chronic illness; specifically, the study of variables that mediate or moderate interactions between environmental influences, biology, and behavior. I am particularly motivated to identify molecular biomarkers that can be utilized to improve risk assessment, early detection, and or targeted interventions for cancer and neurodegenerative disorders that share overlapping molecular pathways and clinical management challenges.
